| Literature DB >> 3620270 |
J G Martinez, S I Murakami, M A Scheinberg.
Abstract
1 Isoxicam was found to inhibit monocyte and neutrophil cell chemotaxis at therapeutic concentrations. 2 The effect was observed after in vitro incubation of normal cells and in vivo in patients with rheumatoid arthritis. 3 Compared to other NSAIDs studied in our laboratory, isoxicam was shown to have a broader spectrum of inhibitory action on the cells involved in the chronic inflammation associated with rheumatoid arthritis.Entities:
Mesh:
Substances:
Year: 1986 PMID: 3620270 PMCID: PMC1400968 DOI: 10.1111/j.1365-2125.1986.tb02991.x
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN: 0306-5251 Impact factor: 4.335